APOE and metabolic dysfunction-associated steatotic liver disease: Results indicated that genetic predisposition to increased Apo-E correlated with a higher NAFLD risk (OR per 1-SD increase in plasma protein level (OR [95% CI] = 1.59 [1.3, 1.94]; PFDR = 4.28 × 10–3).